Form 8-K - Current report:
SEC Accession No. 0001564590-21-043996
Filing Date
2021-08-12
Accepted
2021-08-12 16:19:59
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rptx-8k_20210812.htm   iXBRL 8-K 42457
2 EX-99.1 rptx-ex991_6.htm EX-99.1 328812
3 GRAPHIC gyrepbpvy1v1000001.jpg GRAPHIC 11290
  Complete submission text file 0001564590-21-043996.txt   539791

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rptx-20210812.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20210812_lab.xml EX-101.LAB 20943
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20210812_pre.xml EX-101.PRE 12526
7 EXTRACTED XBRL INSTANCE DOCUMENT rptx-8k_20210812_htm.xml XML 3797
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 211167854
SIC: 2834 Pharmaceutical Preparations